ICD-10 code for erythroblastopenia

The ICD-10-CM code for erythroblastopenia is D60.9 (Acquired pure red cell aplasia, unspecified). The official index lists 1 more specific code, so check the documentation for details such as type, cause, site or severity before settling on D60.9.

Within D60, choose D60.9 (Acquired pure red cell aplasia, unspecified) only when documentation doesn't support a more specific option: chronic acquired pure red cell aplasia (D60.0), transient acquired pure red cell aplasia (D60.1) and other acquired pure red cell aplasias (D60.8).

As a secondary diagnosis it is an MCC (major complication or comorbidity), which can move an inpatient stay into the highest-paying "with MCC" MS-DRG of its family, unless the principal diagnosis excludes it.

In MS-DRG v44.0, it is part of the grouping logic for DRG 808 (Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with MCC, relative weight 2.1705), DRG 809 (Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders with CC, relative weight 1.2262) and DRG 810 (Major Hematological and Immunological Diagnoses Except Sickle Cell Crisis and Coagulation Disorders without CC/MCC, relative weight 1.075), in MDC 16 (Diseases and Disorders of the Blood and Blood Forming Organs and Immunological Disorders), as a principal or secondary diagnosis. The DRG a claim lands in depends on the principal diagnosis, procedures and any CC/MCC secondary diagnoses.